Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 722 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

AstraZeneca to begin PAD study with ticagrelor

The randomised, double-blind study will evaluate the efficacy of ticagrelor compared to clopidogrel in reducing the primary endpoint, a composite of CV death, MI or ischaemic stroke, in

Innophos takes over AMT Labs

AMT is involved in manufacturing mineral ingredients essential to the human diet in the form of chelates as well as custom ingredients for the food, beverage, confectionary and